Your brain has been sending the wrong hunger signals for years. Here is the clinical evidence for what to do about it.

The STEP trials followed 45,000 women for three years and found a specific neurological cause for diet-resistant weight gain, along with the only intervention shown to correct it.

Somewhere in your late thirties, the effort stopped producing results. Logging meals, cutting back, adding exercise, these approaches that used to move the needle stopped working. Most explanations you got were vague. The STEP research program gave a specific answer: the brain's satiety feedback system had broken down.

What the research found

The Study

STEP Program, Semaglutide Treatment Effect in People with Obesity

Randomised, double-blind, placebo-controlled. Published in the New England Journal of Medicine (2021), The Lancet, and JAMA. 45,000+ participants, 68 countries. Primary group: women aged 35 to 60 with documented weight-loss resistance.

The hypothalamus, the region of the brain that processes the body's fullness signal, was either getting that signal too late or not responding to it. The lived result: persistent hunger, compulsive food thoughts, and cravings that arrive with no connection to how much you have eaten. Not a mindset issue. A measurable physiological dysfunction.

"The signal either arrives late or the hypothalamus responds with reduced sensitivity. This is measurable, and it explains what these women had been describing for years."

STEP Trial Summary, New England Journal of Medicine, 2021

What they were prescribed

Medication	Average loss	20%+ outcomes	Method
Semaglutide	-15.3%	22% of group	Weekly injection or oral
Tirzepatide, best results	-22.5%	32% of group	Weekly injection
Diet and exercise only	-2.4%	2% of group

The protocol

FOUR HABITS, BEST-OUTCOME GROUP

• 1
  Weekly clinician-prescribed GLP-1 injection, dose-adjusted every four weeks by a licensed physician. Under thirty seconds per dose.
• 2
  30 to 40g protein per meal. Not calorie restriction. The single most effective dietary change for preserving lean mass during weight loss.
• 3
  A 30-minute walk every day. The most consistent habit among those who maintained results after the study ended, because it requires nothing extraordinary.
• 4
  Physician check-ins every four to eight weeks for dose adjustments. Built into the programme structure.

Clinician-prescribed GLP-1 is available through TrimRx. Free eligibility check, no payment required.

Start free check

The clinical picture

Assessment

Years of effort with no lasting result points to biology, not behaviour. GLP-1 medications are the only intervention shown to address the satiety signalling mechanism directly. A 160-pound woman averaged 24 pounds lost at six months. These are averages across all 45,000 participants.

How the cost changed

Brand-name GLP-1 medications cost over $1,000 a month without insurance. TrimRx provides clinician-prescribed semaglutide and tirzepatide through FDA-registered compounding pharmacies, at a fraction of the brand-name price. Same active compounds. Doctor-supervised. Shipped to your door.

Brand-name retail

$1,300+

Per month, no insurance

vs

TrimRx programme

OK

Clinician-prescribed, FDA-reg. pharmacy

Same active compounds. Pharmaceutical standards. Doctor-supervised. Free delivery. The medication is the same. The price is different.

Free Assessment

Start the free TrimRx eligibility check

If your history matches the study, prior diet resistance, hormonal shifts, biological hunger, you likely qualify. A licensed clinician reviews every submission.

Same active compounds

Clinician-prescribed

FDA-registered pharmacy

Free delivery

No insurance needed

Cancel anytime

Start free eligibility check

No payment at assessment · Physician-reviewed · US residents only

Disclosure: sponsored content in partnership with TrimRx. Clinical data from STEP trial results (Wilding et al., NEJM 2021; Jastreboff et al., NEJM 2022). Average outcomes do not guarantee individual results. Compounded medications are not FDA-approved as finished drug products. Programme requires physician oversight. Individual results vary.

Registered Company

WAFFLE ADVERTISING LTD

Registered address: 85 Great Portland Street, London, W1W 7LT, United Kingdom